Small Molecule Inhibitors of Bcl-2 Family Proteins for Pancreatic Cancer Therapy

Small Molecule Inhibitors of Bcl-2 Family Proteins for Pancreatic Cancer Therapy

Pancreatic cancer (PC) has a complex etiology and displays a wide range of cellular escape pathways that allow it to resist different treatment modalities. Crucial signaling molecules that function downstream of the survival pathways, particularly at points where several of these pathways crosstalk,...

Full description

Bibliographic Details
Main Authors:	Masood, Ashiq, Azmi, Asfar S., Mohammad, Ramzi M.
Format:	Online
Language:	English
Published:	Molecular Diversity Preservation International (MDPI) 2011
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3134295/

Similar Items

Progress in Nanotechnology Based Approaches to Enhance the Potential of Chemopreventive Agents
by: Muqbil, Irfana, et al.
Published: (2011)

Small molecule tyrosine kinase inhibitors in pancreatic cancer
by: Gupta, Sachin, et al.
Published: (2008)

Pan-Bcl-2 Inhibitor AT-101 Enhances Tumor Cell Killing by EGFR Targeted T Cells
by: Thakur, Archana, et al.
Published: (2012)

Anti-cancer drug discovery and development: Bcl-2 family small molecule inhibitors
by: Liu, Qiang, et al.
Published: (2012)

Imaging Cellular Distribution of Bcl Inhibitors Using Small Molecule Drug Conjugates
by: Giedt, Randy J., et al.
Published: (2014)

Nuclear retention of Fbw7 by specific inhibitors of nuclear export leads to Notch1 degradation in pancreatic cancer
by: Gao, Jiankun, et al.
Published: (2014)

Small-molecule inhibitor of Bcl-2 (TW-37) suppresses growth and enhances cisplatin-induced apoptosis in ovarian cancer cells
by: Wang, Haixia, et al.
Published: (2015)

An antiapoptotic Bcl-2 family protein index predicts the response of leukaemic cells to the pan-Bcl-2 inhibitor S1
by: Zhang, Z, et al.
Published: (2013)

The Role of microRNAs in the Diagnosis and Treatment of Pancreatic Adenocarcinoma
by: Diab, Maria, et al.
Published: (2016)

Nab-paclitaxel: potential for the treatment of advanced pancreatic cancer
by: Al-Hajeili, Marwan, et al.
Published: (2014)

Radiosensitization by a novel Bcl-2 and Bcl-XL inhibitor S44563 in small-cell lung cancer
by: Loriot, Y, et al.
Published: (2014)

A small molecule inhibitor of atypical protein kinase C signaling inhibits pancreatic cancer cell transformed growth and invasion
by: Butler, Amanda M., et al.
Published: (2015)

Network insights on oxaliplatin anti-cancer mechanisms
by: Alian, Osama M, et al.
Published: (2012)

Bcl-2 family member Bcl-G is not a proapoptotic protein
by: Giam, M, et al.
Published: (2012)

The Role of Bcl-2 Family Proteins in Therapy Responses of Malignant Astrocytic Gliomas: Bcl2L12 and Beyond
by: Kouri, Fotini M., et al.
Published: (2012)

New targets for therapy in breast cancer: Small molecule tyrosine kinase inhibitors
by: Lin, Nancy U, et al.
Published: (2004)

Targeting DDX3 with a small molecule inhibitor for lung cancer therapy
by: Bol, Guus M, et al.
Published: (2015)

BH3 Response Profiles From Neuroblastoma Mitochondria Predict Activity of Small Molecule Bcl-2 Family Antagonists
by: Goldsmith, Kelly C., et al.
Published: (2009)

HER2 therapy. Small molecule HER-2 tyrosine kinase inhibitors
by: Spector, Neil, et al.
Published: (2007)

Small molecule inhibitors of the p53-MDM2 protein-protein interaction
by: Fitzgerald, Ross Patrick
Published: (2011)

Computationally designed high specificity inhibitors delineate the roles of BCL2 family proteins in cancer
by: Berger, Stephanie, et al.
Published: (2016)

Erratum: The First Small-Molecule Inhibitors of Members of the Ribonuclease E Family
by: Kime, Louise, et al.
Published: (2015)

The First Small-Molecule Inhibitors of Members of the Ribonuclease E Family
by: Kime, Louise, et al.
Published: (2015)

ABT-737, a small molecule Bcl-2/Bcl-xL antagonist, increases antimitotic-mediated apoptosis in human prostate cancer cells
by: Parrondo, Ricardo, et al.
Published: (2013)

Small-Molecule Inhibitors That Target Protein–Protein Interactions in the RAD51 Family of Recombinases
by: Scott, Duncan E, et al.
Published: (2015)

Small-Molecule Inhibitors of the Receptor Tyrosine Kinases: Promising Tools for Targeted Cancer Therapies
by: Hojjat-Farsangi, Mohammad
Published: (2014)

Small Molecule Inhibitors of CXCR4
by: Debnath, Bikash, et al.
Published: (2013)

Small Molecule Inhibitors of Human Papillomavirus Protein - Protein Interactions
by: D’Abramo, C.M, et al.
Published: (2011)

Targeted therapy against Bcl-2-related proteins in breast cancer cells
by: Emi, Manabu, et al.
Published: (2005)

Small-molecule targeting of translation initiation for cancer therapy
by: Aktas, Bertal H., et al.
Published: (2013)

Small Molecule Bax Agonists for Cancer Therapy
by: Xin, Meiguo, et al.
Published: (2014)

Enzyme kinetics and distinct modulation of the protein kinase N family of kinases by lipid activators and small molecule inhibitors
by: Falk, Matthew D., et al.
Published: (2014)

An Optically Pure Apogossypolone Derivative as Potent Pan-Active Inhibitor of Anti-Apoptotic Bcl-2 Family Proteins
by: Wei, Jun, et al.
Published: (2011)

BCL2DB: database of BCL-2 family members and BH3-only proteins
by: Rech de Laval, Valentine, et al.
Published: (2014)

Small-Molecule Inhibitors of the MDM2–p53 Protein–Protein Interaction (MDM2 Inhibitors) in Clinical Trials for Cancer Treatment: Miniperspective
by: Zhao, Yujun, et al.
Published: (2014)

Targeting of the MYCN Protein with Small Molecule c-MYC Inhibitors
by: Müller, Inga, et al.
Published: (2014)

Small‐Molecule and Peptide Inhibitors of the Pro‐Survival Protein Mcl‐1
by: Beekman, Andrew M., et al.
Published: (2015)

Structural Elucidation of a Small Molecule Inhibitor of Protein Disulfide Isomerase
by: Kaplan, Anna, et al.
Published: (2015)

Small Molecule Inhibitors Targeting Activator Protein 1 (AP-1): Miniperspective
by: Ye, Na, et al.
Published: (2014)

Nanomolar-Potency Small Molecule Inhibitor of STAT5 Protein
by: Cumaraswamy, Abbarna A., et al.
Published: (2014)